JP2019514376A5 - - Google Patents

Download PDF

Info

Publication number
JP2019514376A5
JP2019514376A5 JP2018555963A JP2018555963A JP2019514376A5 JP 2019514376 A5 JP2019514376 A5 JP 2019514376A5 JP 2018555963 A JP2018555963 A JP 2018555963A JP 2018555963 A JP2018555963 A JP 2018555963A JP 2019514376 A5 JP2019514376 A5 JP 2019514376A5
Authority
JP
Japan
Prior art keywords
molecule
nucleic acid
funa
vector
target
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018555963A
Other languages
English (en)
Japanese (ja)
Other versions
JP7184648B2 (ja
JP2019514376A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2017/059331 external-priority patent/WO2017186550A1/en
Publication of JP2019514376A publication Critical patent/JP2019514376A/ja
Publication of JP2019514376A5 publication Critical patent/JP2019514376A5/ja
Priority to JP2022187824A priority Critical patent/JP2023018093A/ja
Application granted granted Critical
Publication of JP7184648B2 publication Critical patent/JP7184648B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018555963A 2016-04-29 2017-04-20 標的核酸の改変のための改善された方法 Active JP7184648B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022187824A JP2023018093A (ja) 2016-04-29 2022-11-24 標的核酸の改変のための改善された方法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP16167774.5 2016-04-29
EP16167773 2016-04-29
EP16167774 2016-04-29
EP16167773.7 2016-04-29
EP17156018 2017-02-14
EP17156018.8 2017-02-14
PCT/EP2017/059331 WO2017186550A1 (en) 2016-04-29 2017-04-20 Improved methods for modification of target nucleic acids

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022187824A Division JP2023018093A (ja) 2016-04-29 2022-11-24 標的核酸の改変のための改善された方法

Publications (3)

Publication Number Publication Date
JP2019514376A JP2019514376A (ja) 2019-06-06
JP2019514376A5 true JP2019514376A5 (cg-RX-API-DMAC7.html) 2020-06-11
JP7184648B2 JP7184648B2 (ja) 2022-12-06

Family

ID=58640844

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018555963A Active JP7184648B2 (ja) 2016-04-29 2017-04-20 標的核酸の改変のための改善された方法
JP2022187824A Pending JP2023018093A (ja) 2016-04-29 2022-11-24 標的核酸の改変のための改善された方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022187824A Pending JP2023018093A (ja) 2016-04-29 2022-11-24 標的核酸の改変のための改善された方法

Country Status (12)

Country Link
US (5) US11608499B2 (cg-RX-API-DMAC7.html)
EP (5) EP4166661A1 (cg-RX-API-DMAC7.html)
JP (2) JP7184648B2 (cg-RX-API-DMAC7.html)
KR (3) KR20230038804A (cg-RX-API-DMAC7.html)
CN (1) CN109072207B (cg-RX-API-DMAC7.html)
AU (5) AU2017256517B2 (cg-RX-API-DMAC7.html)
CA (1) CA3022475A1 (cg-RX-API-DMAC7.html)
CL (1) CL2018003074A1 (cg-RX-API-DMAC7.html)
DK (1) DK3448990T5 (cg-RX-API-DMAC7.html)
IL (1) IL262409B2 (cg-RX-API-DMAC7.html)
MX (2) MX388092B (cg-RX-API-DMAC7.html)
WO (1) WO2017186550A1 (cg-RX-API-DMAC7.html)

Families Citing this family (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2853829C (en) 2011-07-22 2023-09-26 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US9163284B2 (en) 2013-08-09 2015-10-20 President And Fellows Of Harvard College Methods for identifying a target site of a Cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
US9228207B2 (en) 2013-09-06 2016-01-05 President And Fellows Of Harvard College Switchable gRNAs comprising aptamers
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US20150166982A1 (en) 2013-12-12 2015-06-18 President And Fellows Of Harvard College Methods for correcting pi3k point mutations
EP3177718B1 (en) 2014-07-30 2022-03-16 President and Fellows of Harvard College Cas9 proteins including ligand-dependent inteins
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
WO2016073990A2 (en) 2014-11-07 2016-05-12 Editas Medicine, Inc. Methods for improving crispr/cas-mediated genome-editing
US11667911B2 (en) 2015-09-24 2023-06-06 Editas Medicine, Inc. Use of exonucleases to improve CRISPR/CAS-mediated genome editing
SG11201803173VA (en) 2015-10-23 2018-05-30 Harvard College Nucleobase editors and uses thereof
WO2017165826A1 (en) 2016-03-25 2017-09-28 Editas Medicine, Inc. Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
EP4047092B1 (en) 2016-04-13 2025-07-30 Editas Medicine, Inc. Cas9 fusion molecules, gene editing systems, and methods of use thereof
KR20190012229A (ko) 2016-06-01 2019-02-08 케이더블유에스 사아트 에스이 유전자 조작을 위한 하이브리드 핵산 서열
JP7231935B2 (ja) 2016-08-03 2023-03-08 プレジデント アンド フェローズ オブ ハーバード カレッジ アデノシン核酸塩基編集因子およびそれらの使用
CA3033327A1 (en) 2016-08-09 2018-02-15 President And Fellows Of Harvard College Programmable cas9-recombinase fusion proteins and uses thereof
WO2018039438A1 (en) 2016-08-24 2018-03-01 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
WO2018071868A1 (en) 2016-10-14 2018-04-19 President And Fellows Of Harvard College Aav delivery of nucleobase editors
WO2018071663A1 (en) * 2016-10-14 2018-04-19 Emendobio Inc. Rna compositions for genome editing
KR20190089175A (ko) * 2016-11-18 2019-07-30 진에딧 인코포레이티드 표적 핵산 변형을 위한 조성물 및 방법
US10745677B2 (en) 2016-12-23 2020-08-18 President And Fellows Of Harvard College Editing of CCR5 receptor gene to protect against HIV infection
US20190352626A1 (en) * 2017-01-30 2019-11-21 KWS SAAT SE & Co. KGaA Repair template linkage to endonucleases for genome engineering
US12390514B2 (en) 2017-03-09 2025-08-19 President And Fellows Of Harvard College Cancer vaccine
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
JP2020510439A (ja) 2017-03-10 2020-04-09 プレジデント アンド フェローズ オブ ハーバード カレッジ シトシンからグアニンへの塩基編集因子
KR20240116572A (ko) 2017-03-23 2024-07-29 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 핵산 프로그램가능한 dna 결합 단백질을 포함하는 핵염기 편집제
US11560566B2 (en) 2017-05-12 2023-01-24 President And Fellows Of Harvard College Aptazyme-embedded guide RNAs for use with CRISPR-Cas9 in genome editing and transcriptional activation
MX2019015188A (es) 2017-06-15 2020-08-03 Univ California Inserciones de adn no virales orientadas.
US11866726B2 (en) 2017-07-14 2024-01-09 Editas Medicine, Inc. Systems and methods for targeted integration and genome editing and detection thereof using integrated priming sites
EP3658573A1 (en) 2017-07-28 2020-06-03 President and Fellows of Harvard College Methods and compositions for evolving base editors using phage-assisted continuous evolution (pace)
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
AU2018352592C1 (en) 2017-10-16 2025-09-25 Beam Therapeutics, Inc. Uses of adenosine base editors
MX2020004325A (es) 2017-10-27 2020-11-09 Univ California Reemplazo dirigido de receptores de células t endógenos.
EP3724214A4 (en) 2017-12-15 2021-09-01 The Broad Institute Inc. SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING
US11268092B2 (en) 2018-01-12 2022-03-08 GenEdit, Inc. Structure-engineered guide RNA
US12157760B2 (en) 2018-05-23 2024-12-03 The Broad Institute, Inc. Base editors and uses thereof
CN113286880A (zh) 2018-08-28 2021-08-20 旗舰先锋创新Vi有限责任公司 调控基因组的方法和组合物
US12281338B2 (en) 2018-10-29 2025-04-22 The Broad Institute, Inc. Nucleobase editors comprising GeoCas9 and uses thereof
KR102298105B1 (ko) 2019-01-08 2021-09-03 주식회사 엘지에너지솔루션 스웰링 게이지를 구비한 배터리 모듈 및 이를 포함하는 배터리 팩
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
GB2601617B (en) 2019-03-19 2024-02-21 Broad Inst Inc Methods and compositions for editing nucleotide sequences
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
WO2021175759A1 (en) 2020-03-04 2021-09-10 Basf Se Method for the production of constitutive bacterial promoters conferring low to medium expression
AU2021230545A1 (en) 2020-03-04 2022-09-29 Flagship Pioneering Innovations Vi, Llc Improved methods and compositions for modulating a genome
KR20220149567A (ko) 2020-03-04 2022-11-08 바스프 에스이 이. 콜라이 및 바실루스에서의 발현을 위한 셔틀 벡터
DE112021002672T5 (de) 2020-05-08 2023-04-13 President And Fellows Of Harvard College Vefahren und zusammensetzungen zum gleichzeitigen editieren beider stränge einer doppelsträngigen nukleotid-zielsequenz
CN112111505B (zh) * 2020-09-17 2022-03-15 江南大学 一种氧化葡萄糖酸杆菌中基因敲除的方法
WO2022251179A1 (en) * 2021-05-26 2022-12-01 Inscripta, Inc. Crispr editing in diploid genomes
EP4384616A4 (en) * 2021-08-11 2025-08-27 Univ Leland Stanford Junior HIGH-THROUGHPUT PRECISION GENOME EDITING IN HUMAN CELLS
WO2023064928A2 (en) 2021-10-14 2023-04-20 Arsenal Biosciences, Inc. Immune cells having co-expressed shrnas and logic gate systems
WO2023114872A2 (en) * 2021-12-14 2023-06-22 The Broad Institute, Inc. Reprogrammable fanzor polynucleotides and uses thereof
US20230374480A1 (en) 2022-03-01 2023-11-23 BASF Agricultural Solutions Seed US LLC Cas12a nickases
CN114774420B (zh) * 2022-04-27 2023-09-22 扬州大学 一种水稻增强子及基于CRISPR/Cas9技术评估水稻增强子活性的方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5565350A (en) 1993-12-09 1996-10-15 Thomas Jefferson University Compounds and methods for site directed mutations in eukaryotic cells
US6027945A (en) 1997-01-21 2000-02-22 Promega Corporation Methods of isolating biological target materials using silica magnetic particles
US6555732B1 (en) 1998-09-14 2003-04-29 Pioneer Hi-Bred International, Inc. Rac-like genes and methods of use
EP1152058A1 (en) 2000-05-03 2001-11-07 Institut Curie Methods and compositions for effecting homologous recombination
DK3284833T3 (da) 2005-08-26 2022-02-07 Dupont Nutrition Biosci Aps Anvendelse af crispr-associerede gener (cas)
AU2014235794A1 (en) * 2013-03-14 2015-10-22 Caribou Biosciences, Inc. Compositions and methods of nucleic acid-targeting nucleic acids
EP3620524A1 (en) 2013-06-17 2020-03-11 The Broad Institute, Inc. Delivery, engineering and optimization of systems, methods and compositions for targeting and modeling diseases and disorders of post mitotic cells
US10563225B2 (en) * 2013-07-26 2020-02-18 President And Fellows Of Harvard College Genome engineering
US10968462B2 (en) 2013-08-12 2021-04-06 BASF Agro B.V. Plants having increased tolerance to herbicides
WO2015092706A1 (en) 2013-12-18 2015-06-25 BASF Agro B.V. Plants having increased tolerance to herbicides
CA2951707A1 (en) * 2014-06-10 2015-12-17 Massachusetts Institute Of Technology Method for gene editing
US20170306306A1 (en) * 2014-10-24 2017-10-26 Life Technologies Corporation Compositions and Methods for Enhancing Homologous Recombination
EP3294879A4 (en) 2015-05-14 2019-02-20 University of Southern California OPTIMIZED GENETIZATION WITH A RECOMBINANT ENDONUCLEASE SYSTEM
WO2017024047A1 (en) 2015-08-03 2017-02-09 Emendobio Inc. Compositions and methods for increasing nuclease induced recombination rate in cells
JP2018532402A (ja) 2015-09-24 2018-11-08 クリスパー セラピューティクス アーゲー Rnaプログラム可能エンドヌクレアーゼの新規のファミリーならびにゲノム編集および他の適用におけるそれらの使用
EP3356520B1 (en) * 2015-10-02 2022-03-23 The U.S.A. as represented by the Secretary, Department of Health and Human Services Lentiviral protein delivery system for rna-guided genome editing
CN106811479B (zh) * 2015-11-30 2019-10-25 中国农业科学院作物科学研究所 利用CRISPR/Cas9系统定点修饰ALS基因获得抗除草剂水稻的系统及其应用
WO2017180711A1 (en) * 2016-04-13 2017-10-19 Editas Medicine, Inc. Grna fusion molecules, gene editing systems, and methods of use thereof
KR20190089175A (ko) * 2016-11-18 2019-07-30 진에딧 인코포레이티드 표적 핵산 변형을 위한 조성물 및 방법

Similar Documents

Publication Publication Date Title
JP2019514376A5 (cg-RX-API-DMAC7.html)
BR112017022852A2 (pt) polipeptídeo recombinante com atividade pesticida, composição, molécula de ácido nucleico recombinante, ácido nucleico recombinante, célula hospedeira, construto de dna, vetor, método para controlar uma população de pragas, método para produzir um polipeptídeo, planta, semente transgênica, método para proteger uma planta e método para aumentar o rendimento em uma planta
CN109072207A (zh) 用于修饰靶核酸的改进方法
BR122023016256B8 (pt) Polipeptídeo inseticida recombinante, polinucleotídeo recombinante, construto de dna, método de obtenção de uma planta transgênica ou célula de planta transgênica, composição, proteína de fusão, método para controlar uma praga, método para inibir crescimento ou para exterminar uma população de pragas e uso do polipeptídeo
BR112017025929A2 (pt) genes pesticidas e métodos de uso
RU2017134741A (ru) Полипептиды транспозазы и их применение
BR112016005543A2 (pt) construto de dna, polinucleotídeo isolado, polinucleotídeo isolado de dna, cassete de expressão, planta transgênica, semente, planta da progênie, célula hospedeira, polipeptídeo pip-72 recombinante, composição, proteína de fusão, método para controlar uma população de praga de inseto, método para inibir o crescimento ou matar uma praga de inseto, método para controlar uma infestação de insetos em uma planta transgênica e fornecer o manejo da resistência, método para identificar em uma amostra biológica uma sequência de nucleotídeos que codifica o polipeptídeo pip-72, método para identificar em uma amostra o polipeptídeo pip-72
MX2022000189A (es) Genes pesticidas y metodos de uso.
PH12018501338A1 (en) Pesticidal genes and methods of use
WO2018140859A3 (en) Pesticidal genes and methods of use
BR112019012339A2 (pt) polipeptídeo inseticida recombinante, composição, construto de dna, célula hospedeira, planta transgênica, método para inibir o crescimento ou extermínio de uma praga de inseto ou população de praga, polipeptídeo ipd093 quimérico e proteína de fusão
Davidson et al. Yersinia pseudotuberculosis: cultivation, storage, and methods for introducing DNA
BR112017022383A2 (pt) polipeptídeo recombinante, composição, molécula de ácido nucleico recombinante, ácido nucleico recombinante, célula hospedeira, construto de dna, vetor, método para controlar uma população de pragas, método para produzir um polipeptídeo, planta, semente transgênica da planta, método para proteger uma planta, método para aumentar o rendimento em uma planta
BR112017013633A2 (pt) polipeptídeo recombinante, molécula de ácido nucleico recombinante, composição, célula hospedeira, construto de dna, vetor, método para controlar uma população de pragas, método para produzir um polipeptídeo com atividade pesticida, planta, semente transgênica, método para proteger uma planta de uma praga de insetos, método para aumentar o rendimento em uma planta
PH12021550691A1 (en) Pesticidal genes and methods of use
RU2626590C2 (ru) Генетическая конструкция для экспрессии генов в клетках насекомого polypedilum vanderplanki
RU2018145686A (ru) Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов SHH, CTNNB1, NOG, WNT7A для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-SHH или Escherichia coli SCS110-AF/VTvaf17-CTNNB1 или Escherichia coli SCS110-AF/VTvaf17-NOG или Escherichia coli SCS110-AF/VTvaf17-WNT7A, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
RU2018145694A (ru) Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов NOS2, NOS3, VIP, KCNMA1, CGRP, для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-NOS2, или Escherichia coli SCS110-AF/VTvaf17-NOS3, или Escherichia coli SCS110-AF/VTvaf17-VIP, или Escherichia coli SCS110-AF/VTvaf17-KCNMA1, или Escherichia coli SCS110-AF/VTvaf17-CGRP, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
CN104131019A (zh) 含MyoDI基因启动子片段的重组质粒的构建方法
CN119751611A (zh) 小立碗藓复制起始位点片段及鉴定方法与应用
RU2018143698A (ru) Генотерапевтический ДНК-вектор на основе генотерапевтического ДНК-вектора VTvaf17, несущий целевой ген, выбранный из группы генов SOD1, SOD2, SOD3, CAT для повышения уровня экспрессии этих целевых генов, способ его получения и применения, штамм Escherichia coli SCS110-AF/VTvaf17-SOD1 или Escherichia coli SCS110-AF/VTvaf17-SOD2 или Escherichia coli SCS110-AF/VTvaf17-SOD3 или Escherichia coli SCS110-AF/VTvaf17-CAT, несущий генотерапевтический ДНК-вектор, способ его получения, способ производства в промышленных масштабах генотерапевтического ДНК-вектора
CN103849640A (zh) 一种寡核苷酸和可消除质粒共转化用于大肠杆菌必需基因点突变的方法
AR111369A1 (es) Genes pesticidas y métodos de uso
AR113099A1 (es) Genes pesticidas y métodos de uso
EP4036105A3 (en) Pesticidal genes and methods of use